Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a valuable class of drugs in the management of type 2 diabetes mellitus. These agents mimic the actions of naturally occurring GLP-1, enhancing insulin https://one-bookmark.com/story19801637/emerging-glucagon-like-peptide-1-receptor-agonists-a-comprehensive-review